Refining the diagnosis of huntington disease: The PREDICT-HD study

Kevin M. Biglan, Ying Zhang, Jeffrey D. Long, Michael Geschwind, Gail A. Kang, Annie Killoran, Wenjing Lu, Elizabeth McCusker, James A. Mills, Lynn A. Raymond, Claudia Testa, Joanne Wojcieszek, Jane S. Paulsen

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Participants with the gene expansion for Huntington disease (HD) but not yet diagnosed were evaluated annually. Unidimensional diagnosis (UD) was a motor diagnosis defined as a diagnostic confidence level (DCL) of 4 (unequivocal motor signs, ≥99% confidence) on the standardized motor exam of the Unified Huntington Disease Rating Scale (UHDRS). Multidimensional diagnosis (MD) was defined as answering yes on Question 80 (Q80) of the UHDRS, ≥99% confidence of manifest HD based on the entire UHDRS. Motor, cognitive, and behavioral measures of phenotype at first diagnosis were compared by t-tests between participants diagnosed via motor exam (UD) and those diagnosed via multidimensional input (MD). Cluster analysis identified clusters based on UHDRS domains.186 participants received a diagnosis of HD during a maximum of 6.4 years of follow-up. In 108 (58.1%) the diagnosis by MD and UD occurred simultaneously, while in 69 (37.1%) the diagnosis by MD occurred prior to UD. Participants who were diagnosed by MD prior to UD were less impaired on motor (12.2 ± 6.7 vs. 22.4 ± 9.3, p < 0.0001), and cognitive (290.7 ± 56.2 vs. 258.0 ± 53.7, p = 0.0002), but not behavioral measures (16.3 ± 21.2 vs. 18.6 ± 22.1, p = 0.49) when compared with those diagnosed simultaneously. Cluster analysis identified three clusters that represented primarily cognitively impaired, behaviorally impaired, and cognitively preserved phenotypes. A multidimensional method results in an earlier diagnosis with less motor and cognitive impairment than a motor diagnosis. Findings have implications for designing preventive trials and providing clinical care in prodromal HD.

Original languageEnglish
Article numberArticle 12
JournalFrontiers in Aging Neuroscience
Volume5
Issue numberAPR
DOIs
StatePublished - 2013

Fingerprint

Huntington Disease
Cluster Analysis
Phenotype
Early Diagnosis

Keywords

  • Cohort studies
  • Huntington's disease
  • Natural history studies
  • Outcome research
  • Trinucleotide repeat diseases

ASJC Scopus subject areas

  • Aging
  • Cognitive Neuroscience

Cite this

Biglan, K. M., Zhang, Y., Long, J. D., Geschwind, M., Kang, G. A., Killoran, A., ... Paulsen, J. S. (2013). Refining the diagnosis of huntington disease: The PREDICT-HD study. Frontiers in Aging Neuroscience, 5(APR), [Article 12]. https://doi.org/10.3389/fnagi.2013.00012

Refining the diagnosis of huntington disease : The PREDICT-HD study. / Biglan, Kevin M.; Zhang, Ying; Long, Jeffrey D.; Geschwind, Michael; Kang, Gail A.; Killoran, Annie; Lu, Wenjing; McCusker, Elizabeth; Mills, James A.; Raymond, Lynn A.; Testa, Claudia; Wojcieszek, Joanne; Paulsen, Jane S.

In: Frontiers in Aging Neuroscience, Vol. 5, No. APR, Article 12, 2013.

Research output: Contribution to journalArticle

Biglan, KM, Zhang, Y, Long, JD, Geschwind, M, Kang, GA, Killoran, A, Lu, W, McCusker, E, Mills, JA, Raymond, LA, Testa, C, Wojcieszek, J & Paulsen, JS 2013, 'Refining the diagnosis of huntington disease: The PREDICT-HD study', Frontiers in Aging Neuroscience, vol. 5, no. APR, Article 12. https://doi.org/10.3389/fnagi.2013.00012
Biglan, Kevin M. ; Zhang, Ying ; Long, Jeffrey D. ; Geschwind, Michael ; Kang, Gail A. ; Killoran, Annie ; Lu, Wenjing ; McCusker, Elizabeth ; Mills, James A. ; Raymond, Lynn A. ; Testa, Claudia ; Wojcieszek, Joanne ; Paulsen, Jane S. / Refining the diagnosis of huntington disease : The PREDICT-HD study. In: Frontiers in Aging Neuroscience. 2013 ; Vol. 5, No. APR.
@article{73e3e94a276647438ef73fd109ae3eed,
title = "Refining the diagnosis of huntington disease: The PREDICT-HD study",
abstract = "Participants with the gene expansion for Huntington disease (HD) but not yet diagnosed were evaluated annually. Unidimensional diagnosis (UD) was a motor diagnosis defined as a diagnostic confidence level (DCL) of 4 (unequivocal motor signs, ≥99{\%} confidence) on the standardized motor exam of the Unified Huntington Disease Rating Scale (UHDRS). Multidimensional diagnosis (MD) was defined as answering yes on Question 80 (Q80) of the UHDRS, ≥99{\%} confidence of manifest HD based on the entire UHDRS. Motor, cognitive, and behavioral measures of phenotype at first diagnosis were compared by t-tests between participants diagnosed via motor exam (UD) and those diagnosed via multidimensional input (MD). Cluster analysis identified clusters based on UHDRS domains.186 participants received a diagnosis of HD during a maximum of 6.4 years of follow-up. In 108 (58.1{\%}) the diagnosis by MD and UD occurred simultaneously, while in 69 (37.1{\%}) the diagnosis by MD occurred prior to UD. Participants who were diagnosed by MD prior to UD were less impaired on motor (12.2 ± 6.7 vs. 22.4 ± 9.3, p < 0.0001), and cognitive (290.7 ± 56.2 vs. 258.0 ± 53.7, p = 0.0002), but not behavioral measures (16.3 ± 21.2 vs. 18.6 ± 22.1, p = 0.49) when compared with those diagnosed simultaneously. Cluster analysis identified three clusters that represented primarily cognitively impaired, behaviorally impaired, and cognitively preserved phenotypes. A multidimensional method results in an earlier diagnosis with less motor and cognitive impairment than a motor diagnosis. Findings have implications for designing preventive trials and providing clinical care in prodromal HD.",
keywords = "Cohort studies, Huntington's disease, Natural history studies, Outcome research, Trinucleotide repeat diseases",
author = "Biglan, {Kevin M.} and Ying Zhang and Long, {Jeffrey D.} and Michael Geschwind and Kang, {Gail A.} and Annie Killoran and Wenjing Lu and Elizabeth McCusker and Mills, {James A.} and Raymond, {Lynn A.} and Claudia Testa and Joanne Wojcieszek and Paulsen, {Jane S.}",
year = "2013",
doi = "10.3389/fnagi.2013.00012",
language = "English",
volume = "5",
journal = "Frontiers in Aging Neuroscience",
issn = "1663-4365",
publisher = "Frontiers Research Foundation",
number = "APR",

}

TY - JOUR

T1 - Refining the diagnosis of huntington disease

T2 - The PREDICT-HD study

AU - Biglan, Kevin M.

AU - Zhang, Ying

AU - Long, Jeffrey D.

AU - Geschwind, Michael

AU - Kang, Gail A.

AU - Killoran, Annie

AU - Lu, Wenjing

AU - McCusker, Elizabeth

AU - Mills, James A.

AU - Raymond, Lynn A.

AU - Testa, Claudia

AU - Wojcieszek, Joanne

AU - Paulsen, Jane S.

PY - 2013

Y1 - 2013

N2 - Participants with the gene expansion for Huntington disease (HD) but not yet diagnosed were evaluated annually. Unidimensional diagnosis (UD) was a motor diagnosis defined as a diagnostic confidence level (DCL) of 4 (unequivocal motor signs, ≥99% confidence) on the standardized motor exam of the Unified Huntington Disease Rating Scale (UHDRS). Multidimensional diagnosis (MD) was defined as answering yes on Question 80 (Q80) of the UHDRS, ≥99% confidence of manifest HD based on the entire UHDRS. Motor, cognitive, and behavioral measures of phenotype at first diagnosis were compared by t-tests between participants diagnosed via motor exam (UD) and those diagnosed via multidimensional input (MD). Cluster analysis identified clusters based on UHDRS domains.186 participants received a diagnosis of HD during a maximum of 6.4 years of follow-up. In 108 (58.1%) the diagnosis by MD and UD occurred simultaneously, while in 69 (37.1%) the diagnosis by MD occurred prior to UD. Participants who were diagnosed by MD prior to UD were less impaired on motor (12.2 ± 6.7 vs. 22.4 ± 9.3, p < 0.0001), and cognitive (290.7 ± 56.2 vs. 258.0 ± 53.7, p = 0.0002), but not behavioral measures (16.3 ± 21.2 vs. 18.6 ± 22.1, p = 0.49) when compared with those diagnosed simultaneously. Cluster analysis identified three clusters that represented primarily cognitively impaired, behaviorally impaired, and cognitively preserved phenotypes. A multidimensional method results in an earlier diagnosis with less motor and cognitive impairment than a motor diagnosis. Findings have implications for designing preventive trials and providing clinical care in prodromal HD.

AB - Participants with the gene expansion for Huntington disease (HD) but not yet diagnosed were evaluated annually. Unidimensional diagnosis (UD) was a motor diagnosis defined as a diagnostic confidence level (DCL) of 4 (unequivocal motor signs, ≥99% confidence) on the standardized motor exam of the Unified Huntington Disease Rating Scale (UHDRS). Multidimensional diagnosis (MD) was defined as answering yes on Question 80 (Q80) of the UHDRS, ≥99% confidence of manifest HD based on the entire UHDRS. Motor, cognitive, and behavioral measures of phenotype at first diagnosis were compared by t-tests between participants diagnosed via motor exam (UD) and those diagnosed via multidimensional input (MD). Cluster analysis identified clusters based on UHDRS domains.186 participants received a diagnosis of HD during a maximum of 6.4 years of follow-up. In 108 (58.1%) the diagnosis by MD and UD occurred simultaneously, while in 69 (37.1%) the diagnosis by MD occurred prior to UD. Participants who were diagnosed by MD prior to UD were less impaired on motor (12.2 ± 6.7 vs. 22.4 ± 9.3, p < 0.0001), and cognitive (290.7 ± 56.2 vs. 258.0 ± 53.7, p = 0.0002), but not behavioral measures (16.3 ± 21.2 vs. 18.6 ± 22.1, p = 0.49) when compared with those diagnosed simultaneously. Cluster analysis identified three clusters that represented primarily cognitively impaired, behaviorally impaired, and cognitively preserved phenotypes. A multidimensional method results in an earlier diagnosis with less motor and cognitive impairment than a motor diagnosis. Findings have implications for designing preventive trials and providing clinical care in prodromal HD.

KW - Cohort studies

KW - Huntington's disease

KW - Natural history studies

KW - Outcome research

KW - Trinucleotide repeat diseases

UR - http://www.scopus.com/inward/record.url?scp=84876339553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876339553&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2013.00012

DO - 10.3389/fnagi.2013.00012

M3 - Article

C2 - 23565093

AN - SCOPUS:84876339553

VL - 5

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

SN - 1663-4365

IS - APR

M1 - Article 12

ER -